Trial intelligence / Profile preview

Lenalidomide with or without dexamethasone in second-line multiple myeloma

NCT01450215Phase 2Completed

Sponsor
Karolinska University Hospital
Start
Mar 2011
Primary completion
Jan 2016
Countries
1
01

Overview

A Phase 2 trial of lenalidomide in multiple myeloma (MM), sponsored by Karolinska University Hospital. Started Mar 2011; status: completed.

02

Drugs

lenalidomide
03

Conditions

multiple myeloma (MM)

Beyond the preview

Go deeper on NCT01450215.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01450215.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call